Company Intelligence

Darmiyan

Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.

In this profile

Quick Facts

  • Founded 2017
  • Headquarters San Francisco, United States
  • Country United States
  • Industry AI in Healthcare
  • Company Type Early
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.

Why It Matters

Early detection of Alzheimer's disease

Recent Developments

  1. 2017 Company founded

    Darmiyan was founded in 2017 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Novel quantitative virtual microscopy for early detection of Alzheimer’s disease from non-invasive MRI.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe